CELLOXESS BIOTECHNOLOGY
ABOUT
CellOxess is solely dedicated to promoting optimal health and wellness by restoring cellular redox balance.
MISSION STATEMENT
WE ARE FIRMLY COMMITTED
To understand the biomolecular role of antioxidants and their synergistic action in maintaining cell homeostasis: this is a critical step for normal tissue function to support, for example, cardiovascular, metabolic, neurological and particularly reproductive health.
​
To apply pharmaceutical standards and practices of R&D to formulate safe and efficacious antioxidant supplements to restore a normal redox balance and support healthy cellular structure and function.
To develop and maintain strong academic research collaborations with pioneering scientists worldwide.
​
To substantiate all marketed products with pre-clinical or clinical evidence published in reputable journals.
MEET THE TEAM
President & CEO USA
PARVIZ GHARAGOZLOO PhD
Dr. Gharagozloo is the founder of CellOxess LLC and currently serves as its president and Chief Executive Officer. He has over 25 years of experience in Organic and Medicinal Chemistry gained in academia, tech transfer, biotech and pharmaceutical companies in the UK and USA. Prior to CellOxess, he led a group of medicinal chemists at Purdue Pharma in Cranbury, NJ targeting receptors, enzymes and ion-channels for the discovery of novel analgesics. Before joining Purdue in 2000, Dr. Gharagozloo was as the head of medicinal chemistry at Napp pharmaceuticals, a pain specializing company in Cambridge, UK where he led multiple research programs in drug discovery and served on the board of directors. He started his professional research career back in 1990 at the Medical Research Council Technology Center at Mill Hill in London, UK, where he spent 3 years as a postdoc and a further 5 years as a senior scientist and later as the head of medicinal chemistry department. He received his honors BSc degree in Chemistry and PhD in Medicinal chemistry in 1990 at University College London, UK. Dr. Gharagozloo has published extensively in the fields of organic and medicinal chemistry. His work is recognized by a number of international patents and he is the sole inventor of Fertilix.
ROBERT
JOHN AITKEN
PhD, ScD, FAHMS,
FRSN,
FRSE,
FAA
Chief Scientific Officer Australia
PRO VICE CHANCELLOR HEALTH & MEDICINE, LAUREATE PROFESSOR BIOLOGICAL SCIENCES, CO-DIRECTOR, PRIORITY RESEARCH CENTRE REPRODUCTIVE SCIENCE UNIVERSITY OF NEWCASTLE, NSW.
​
Laureate Professor Aitken’s research career began with a PhD in reproductive biology from the University of Cambridge. Following post-doctoral positions at the Institute of Animal Genetics, University of Edinburgh and the University of Bordeaux, he joined the World Health Organization in Geneva, where he managed two WHO task forces within the Human Reproduction Unit. In 1977, he joined the Medical Research Council’s Reproductive Biology Unit, University of Edinburgh, to establish a research group in gamete biology with clinical outreach into male infertility. In 1992, John was awarded an Honorary Professorship within the Faculty of Medicine of Edinburgh University and in 1998 he received a ScD degree from the University of Cambridge in recognition of his research contributions to gamete biology. John has published over 500 research articles, given more than 300 invited lectures and filed 12 patents. He has been elected a Fellow of both the Royal Society of Edinburgh and the Australian Academy of Science, was named as the New South Wales Scientist-of-the-Year in 2012, and 2016 recipient of the prestigious Carl G Hartman award. John Aitken is on the Editorial Boards of 8 journals at the present time. His work has been featured on television [Horizon, Tomorrow’s world, Beyond 2000, Catalyst (2x)], radio (Capital radio, SBS radio, ABC national and local radio as well as the BBC’s Cruicible, Science Now and Medicine Now) and printed media including feature articles in the New Scientist, Nature and the Australian.
JOEL R.
DREVET
PhD
Scientific Advisory Board FRANCE
PROFESSOR OF IMMUNOLOGY & REPRODUCTIVE BIOLOGY, UNIVERSITY CLERMONT AUVERGNE; DIRECTOR, EVALSEM BUSINESS UNIT – FACULTY OF MEDICINE, CLERMONT AUVERGNE INNOVATION
Professor Joël Drevet's research focuses on the post-testicular stages of sperm maturation, particularly during their descent and storage in the epididymis. His primary work explores oxidative stress and its impact on sperm fertilization capacity, nuclear integrity, and the transgenerational effects of oxidative damage through genetic and epigenetic modifications. His research is highly relevant to both natural reproduction and assisted reproductive technologies (ART). Additionally, he investigates cholesterol homeostasis and immune regulation in the epididymis, contributing to both basic and clinical sciences in sperm physiology. Professor Drevet is an active member of several prestigious societies, including the European Academy of Andrology (EAA), the European Society of Human Reproduction and Embryology (ESHRE), the North American Society for Reproductive Studies (SSR), and the International Society of Andrology (ISA). He also holds several key editorial roles, serving as Managing Editor of Basic & Clinical Andrology (BaCA), Associate Editor of Asian Journal of Andrology, Oxidative Medicine & Cellular Longevity, and Antioxidants, and Academic Editor of PLoS ONE. In addition, he is a member of the review board for Andrology. Previously, he was Associate Editor of Human Reproduction (2011-2016) and a Review Board Member of Biology of Reproduction (2013-2016). Throughout his career, Professor Drevet's research team has trained more than 18 doctoral students and published over 150 scientific articles. His work has an H-index of 50 and a citation count exceeding 8,500, highlighting his significant contributions to reproductive biology and andrology.
ARON
MOAZAMIAN
PhD
Director, Business Development USA
Aron Moazamian completed an Honors BSc in Biology and Chemistry Minor at The College of New Jersey, Ewing, USA and his PhD at the Université Clermont Auvergne, Clermont-Ferrand, France, in Biology & Health Sciences. His PhD thesis focused on “The impact of redox stress on sperm genetic and epigenetic integrity”. Subsequently, he has been involved in all aspects of the business and demonstrated great acumen and drive in this area. Recognized as a highly gifted individual and leader by senior management, Aron has represented CellOxess at trade shows, scientific conferences and plays a key role in daily domestic and global business operations. Aron’s combination of scientific and business skills uniquely position him as a direct link from CellOxess R&D advancing the company’s initiatives in preventative medicine by isolating areas of unmet clinical need, towards ultimately addressing them with current and future products.
Scientific Advisory Board SPAIN
ALFONSO
GUTIERREZ-ADAN
PhD
DEPARTMENT DIRECTOR ANIMAL REPRODUCTION, INIA-MADRID; LABORATORY DIRECTOR GAMETOGENESIS, EMBRYO DEVELOPMENT AND mRNA SPLICING, INIA-MADRID.
​
Dr. Alfonso Gutierrez-Adan obtained his PhD in Biological Sciences from University of Oviedo in Spain. He then moved to the USA to do his postdoctoral training at the Department of Animal Sciences, University of Davis, CA. In 1997 he returned to Madrid to the Department of Animal Reproduction at INIA as a research scientist. He is now the Head of the “Gametogenesis, embryo development and mRNA splicing” lab (https://laborepro.wixsite.com/gutierrez-adan) and Director of Department of Animal Reproduction, INIA, Madrid Spain. His research team is mainly interested in understanding the molecular events of early mammalian fertilization and embryonic development, and how the quality of gamete/embryos, and reproductive technologies contribute to the adult phenotype. He is a pioneer in the transcriptomic and epigenomic analysis of preimplantation embryos in animal models and farm animals. He has authored or contributed to more than 200 peer reviewed publications, and 40 international invited conferences.
Vice President, Finance USA
KENNETH
CURCIO
BSc
Ken Curcio joined Celloxess in May of 2014. He has over 35 years of experience in the fields of Accounting and Finance. He has spent over 14 years as the Chief Financial Officer at several diverse organizations, and 8 years in public accounting, most recently as a partner with Diversified Accounting Solutions, LLC. His experience includes retail, wholesale, fleet leasing and rental, manufacturing, distribution and non-profit. Ken has provided litigation support and expert testimony in legal cases requiring jury trials. He has particular strengths in budgeting, forecasting, projecting and managing cash flow and financing as these skills relate to small businesses and start-up organizations. He has a proven ability to guide small companies and start-ups to the next level.
JORGE
HALLAK
MD, PhD
Scientific / Medical Advisory Board
BRAZIL
DIRECTOR ANDROSCIENCE, SCIENCE & INNOVATION CENTER IN ANDROLOGY; ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF SAO PAULO MEDICAL SCHOOL; SAO PAULO, BRAZIL.
Professor Jorge Hallak currently serves as an acting Urologist and Associate Professor of Medicine and Coordinator of the Reproductive Toxicology Unit, Department of Pathology at the University of Sao Paulo Medical School, as well as the Technical and Scientific Director of Androscience – Science and Innovation Center in Andrology in Sao Paulo, Brazil. Prof. Hallak’s career began with a medical degree at the University of Sao Paulo, with specializations in surgery and urology. In 1998, he completed a fellowship in Andrology and Male Infertility at the Cleveland Clinic, Department of Urology, with focus in microsurgery as well as sperm cryopreservation, physiology and biochemistry to then complete a PhD in Male Infertility in 1999. Jorge has since published over 70 research articles, 20 book chapters and delivered over 400 presentations at scientific conferences. Jorge has well regarded expertise in the anatomy of the male reproductive and sexual systems, physiology and biochemistry of human spermatozoa, advanced sperm function tests, as well as the influence of environmental pollution on male fertility. Prof. Hallak continues to be a regular contributing member to a number of international medical associations including, but not limited to, American Society of Andrology, American Urological Association, American Society for Reproductive Medicine, Society for the Study of Male Reproduction, International Society of Urology, and the International Society for the Study of the Aging Male. (ANEP).